Martek Biosciences Corp – ‘8-K/A’ for 7/5/02 – EX-23

On: Friday, 7/5/02, at 5:00pm ET · For: 7/5/02 · Accession #: 892025-2-11 · File #: 0-22354

  As Of                Filer                Filing    For·On·As Docs:Size

 7/05/02  Martek Biosciences Corp           8-K/A:7     7/05/02    3:112K

Amendment to Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K/A       Amendment to Current Report                         HTML    165K 
 2: EX-23       Exhibit 23.1                                        HTML     10K 
 3: EX-23       Exhibit 23.2                                        HTML      7K

EX-23 — Exhibit 23.2

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Exhibit 23.2

EXHIBIT 23.2

CONSENT OF DELOITTE & TOUCHE LLP, INDEPENDENT AUDITORS

We consent to the incorporation by reference in Registration Statement Nos. 33-93580, 333-34460, 333-57176, 333-76750, and 333-87934 of Martek Biosciences Corporation on Forms S-3 and Registration Statement Nos. 33-79222, 333-27671, 333-46949, 333-84317, 333-52298, 333-74092, 333-85856 and 333-87016 of Martek Biosciences Corporation on Forms S-8 of our report dated March 26, 2002, (April 25, 2002 as to the fourth paragraph of Note 8) on the consolidated financial statements of OmegaTech, Inc. and Subsidiary as of December 31, 2001 and 2000 and for the years then ended appearing in this Current Report on Form 8-K/A of Martek Biosciences Corporation.

/s/ DELOITTE & TOUCHE LLP

DELOITTE & TOUCHE LLP
Denver, Colorado
July 5, 2002

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K/A’ Filing	Date	Other Filings

Filed on / For Period End:	7/5/02
	4/25/02	8-K, 8-K/A
	3/26/02	8-K
	12/31/01
	12/31/00
		List all Filings

↑Top

Filing Submission 0000892025-02-000011 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)